Skip to main content

Cost-effective reimbursement analysis for medical technologies in Europe

Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 34 EU countries

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Updated Convention for reimbursement of kidney dialysis in Belgium

07 Feb 2024

In Belgium, dialysis is reimbursed under a specific agreement (Convention) between the National Institute for Health and Disability Insurance (INAMI-RIZIV) and chronic kidney failure centers starting in 2018. The current update of the Convention came into force on January 1, 2024, and is valid until December 31, 2026. 

The Convention determines reimbursement amounts and conditions for a hospital and for doctors depending on the type of dialysis. The following types of dialysis are covered by the Convention (same as in the previous version):

  • Chronic hospital hemodialysis (using hemofiltration/ultrafiltration);
  • Chronic home hemodialysis and self-care hemodialysis;
  • Chronic hemodialysis in a collective auto-dialysis center;
  • Chronic home peritoneal dialysis;
  • Pediatric dialysis.

Services are reimbursed via Pseudo-nomenclature codes. 

No significant changes were introduced in the overall reimbursement framework in 2024. Four new Pseudo-nomenclature codes for informing and training patients were added. Some examples of new codes are provided below:

  • 471111 Information and training: new dialysis patients;
  • 471133 Information and training: home dialysis patients, first year (start);

See the full details here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.